Delivery Order SPE2DB24D2205-SPE2DB25FEFLX
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $5,268.40 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,285,746 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,227.19 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The delivery order has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) awarded by DLA, valued at up to $999,999,999.00 with a performance...
- The Defense Logistics Agency awarded a $5,388.87 delivery order to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 mg/4 ml syringes (4 ml quantity) under a firm fixed price contract type. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,070.40 order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
- The Defense Logistics Agency awarded a delivery order valued at $6,708.32 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on July 24, 2025, with completion expected by July 25, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,906.08 firm fixed-price delivery order is for MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,859.06 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,562,814,068 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $3,005.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is part of a larger indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,266.96 on July 18, 2025, for the supply of MONOVISC 88 mg/4 mL syringes (4 mL quantity) under a firm fixed-price contract. The award, which carries an ultimate completion date of July 21, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the company's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a continuation of...